<--- Back to Details
First PageDocument Content
Chemistry / Quality-adjusted life year / Systolic hypertension / Antihypertensive drug / Cost–utility analysis / National Institute for Health and Clinical Excellence / Eprosartan / Hypertension / Nitrendipine / Medicine / Health / Health economics
Date: 2010-09-14 05:17:08
Chemistry
Quality-adjusted life year
Systolic hypertension
Antihypertensive drug
Cost–utility analysis
National Institute for Health and Clinical Excellence
Eprosartan
Hypertension
Nitrendipine
Medicine
Health
Health economics

Microsoft Word - 8150_submit_Gradl.doc

Add to Reading List

Source URL: cardio.by

Download Document from Source Website

File Size: 469,80 KB

Share Document on Facebook

Similar Documents

CMTF005 - Food is Medicine - Checklist_Debranded

DocID: 1xVMk - View Document

Cardiac electrophysiology / Medical devices / Neuroprosthetics / Medicine / Technology / Computing / Cybernetics / Implantable cardioverter-defibrillator / International Statistical Classification of Diseases and Related Health Problems / Universal Software Radio Peripheral / Artificial cardiac pacemaker / Radio-frequency identification

Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin†

DocID: 1xVge - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_with bleed

DocID: 1xUza - View Document

CMTF005 - Food is Medicine - Checklist_Debranded_edited

DocID: 1xTtU - View Document

PDF Document

DocID: 1xSqy - View Document